Back to search results

A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

Abroad (travel likely)RecruitingPHASE3

Conditions

Friedreich Ataxia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UCLA Neurology Outpatient Clinic at Westwood, Los Angeles, California, United States

    Study coordinator · sperlman@mednet.ucla.edu · 310-794-1195
    Contact: Principal Investigator (Susan Perlman)

  • Norman Fixel Institute for Neurological Diseases UF Health, Gainesville, Florida, United States

    Study coordinator · s.subramony@neurology.ufl.edu · 352-733-3032
    Contact: Principal Investigator (Sankarsubramoney Subramony)

  • USF Health Morsani College of Medicine Department of Neurology, Tampa, Florida, United States

    Study coordinator · tzesiewi@hsc.usf.edu · 813-974-5909
    Contact: Principal Investigator (Theresa Zesiewicz)

  • Children's Hospital of Philadelphia - Buerger Center for Advanced Pediatric Care - PIN, Philadelphia, Pennsylvania, United States

    Study coordinator · lynchd@pennmedicine.upenn.edu · 215-590-2242
    Contact: Principal Investigator (David Robinson Lynch)

  • St. Jude Children's Research Hospital - PIN, Memphis, Tennessee, United States

    Study coordinator · richard.finkel@stjude.org · 407-650-7250
    Contact: Principal Investigator (Richard Finkel)

  • CHKD's Health Center - South Campus - PIN, Norfolk, Virginia, United States

    Study coordinator · Proud.research@chkd.org · 757-668-6981
    Contact: Principal Investigator (Crystal Proud)

  • Seattle Children's Hospital, Seattle, Washington, United States

    Study coordinator · 206-987-2078
    Contact: Principal Investigator (Alicia Henriquez)

  • Sydney Children's Hospital, Randwick, New South Wales, Australia

  • Murdoch Childrens Research Institute (MCRI), Parkville, Victoria, Australia

  • Universitätsklinikum Innsbruck, Innsbruck, Austria

    Study coordinator · sylvia.boesch@i-med.ac.at · +43 5125042 3850
    Contact: Principal Investigator (Sylvia M Boesch)

  • L2 Ip - Instituto de Pesquisas Clinicas Ltda - ME, Brasília, Federal District, Brazil

    Study coordinator · eduardo.vasconcellos@l2ip.com.br · +55 61 3445-4300
    Contact: Principal Investigator (Ingrid Faber Faber de Vasconcellos)

  • University of Campinas (UNICAMP) School of Medical Sciences, Campinas, São Paulo, Brazil

    Study coordinator · mcfrancajr@uol.com.br · +55 19 3521-8922
    Contact: Principal Investigator (Marcondes Franca)

  • PSEG Centro de Pesquisa Clinica, São Paulo, São Paulo, Brazil

    Study coordinator · pvsgobbi@gmail.com · +5511972375577
    Contact: Principal Investigator (Paulo Victor Sgobbi de Souza)

  • McGill University, Montreal, Quebec, Canada

    Study coordinator · maryam.oskoui@mcgill.ca · 514-412-4466
    Contact: Principal Investigator (Maryam Oskoui)

  • CHU de Quebec -Universite Laval, Québec, Quebec, Canada

    Study coordinator · nicolas.chrestian.med@ssss.gouv.qc.ca · 418-525-4444
    Contact: Principal Investigator (Nicolas Chrestian)

  • Rigshospitalet - Juliane Marie Centret (JMC) Copenhagen, Copenhagen, Denmark

    Study coordinator · alfred.peter.born@regionh.dk · +45 35-45-50-93
    Contact: Principal Investigator (Alfred Peter Born)

  • CHU de Montpellier- Hôpital Gui De Chauliac, Montpellier, Hérault, France

    Study coordinator · a-roubertie@chu-montpellier.fr · 33 04 67 33 01 82
    Contact: Principal Investigator (Agathe Roubertie)

  • AP-HP - Hôpital Armand Trousseau, Paris, France

    Study coordinator · Florence.renaldo@aphp.fr · +33 1 85 34 00 29
    Contact: Principal Investigator (Florence Renaldo)

  • Universitätsklinikum Aachen, Aachen, North Rhine-Westphalia, Germany

    Study coordinator · kreetz@ukaachen.de · 492418089601
    Contact: Principal Investigator (Kathrin Reetz)

  • UKGM - Universitätsklinikum Giessen und Marburg GmbH - Standort Gießen, Giessen, Germany

    Study coordinator · andreas.hahn@paediat.med.uni-giessen.de · +49 641 985 43543
    Contact: Principal Investigator (Andreas Hahn)

  • Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany

    Study coordinator · d.weiss@uke.de · +49 40 7410 56126
    Contact: Principal Investigator (Deike Weiss)

  • All India Institute of Medical Sciences (AIIMS) - New Delhi, New Delhi, National Capital Territory of Delhi, India

  • CHI at Temple Street, Dublin, Ireland

    Study coordinator · declan.orourke@cuh.ie · (353) 187-8472
    Contact: Principal Investigator (Declan O'Rourke)

  • Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Lazio, Italy

    Study coordinator · gessica.vasco@opbg.net · +39 066859 3461
    Contact: Principal Investigator (Gessica Vasco)

  • IRCCS Eugenio Medea - Polo. Scientifico Veneto, Conegliano, Veneto, Italy

    Study coordinator · gabriella.paparella@lanostrafamiglia.it · +39 3383065324
    Contact: Principal Investigator (Gabriella Paparella)

  • Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

    Study coordinator · isabella.moroni@istituto-besta.it · +39 022394 2210
    Contact: Principal Investigator (Isabella Moroni)

  • Radboud Universitair Medisch Centrum, Nijmegen, Netherlands

    Study coordinator · 31 243614415
    Contact: Principal Investigator (Nienke van Os)

  • King Faisal Specialist Hospital & Research Centre, Riyadh, Ar Riya, Saudi Arabia

  • Hospital Sant Joan de Deu - PIN, Espluges de Llobregat, Barcelona, Spain

    Study coordinator · alejandra.darling@sjd.es · +34 93 253 21 00
    Contact: Principal Investigator (Alejandra Darling)

  • Hospital Universitario La Paz - PPDS, Madrid, Spain

    Study coordinator · yambee@hotmail.com · +34 91 7277388
    Contact: Principal Investigator (Maria del Mar Garcia Romero)

  • Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi, Istanbul, Turkey (Türkiye)

  • University College Hospital - PPDS, London, Lincolnshire, United Kingdom

    Study coordinator · shpresa.pula1@nhs.net · +44 773046 1357
    Contact: Principal Investigator (Shpresa Pula)

  • John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom

    Study coordinator · 44 1865 231556
    Contact: Principal Investigator (Andrea Németh)

  • Sheffield Children's Hospital - PPDS, Sheffield, South Yorkshire, United Kingdom

    Study coordinator · santosh.mordekar@nhs.net · 0114 226 0675
    Contact: Principal Investigator (Santosh Ravindra Mordekar)
Study leads

  • Medical Director

    Study Director

    Biogen

View source on ClinicalTrials.gov(opens in a new tab)